CNBX Pharmaceuticals (CNBX) Short Interest Ratio & Short Volume $0.0040 +0.00 (+5.26%) As of 04/24/2025 03:56 PM Eastern Add Compare Share Share Short Interest Stock AnalysisChartSEC FilingsShort InterestBuy This Stock CNBX Pharmaceuticals Short Interest DataCNBX Pharmaceuticals (CNBX) has a short interest of 3,800 shares. This marks a 3,700.00% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 201,007 shares to cover all short positions.Current Short Interest3,800 sharesPrevious Short Interest100 sharesChange Vs. Previous Month+3,700.00%Dollar Volume Sold Short$28.88Short Interest Ratio0.0 Days to CoverLast Record DateFebruary 28, 2025Today's Trading Volume1,015,158 sharesAverage Trading Volume201,007 sharesToday's Volume Vs. Average505% Short Selling CNBX Pharmaceuticals? Sign up to receive the latest short interest report for CNBX Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartCNBX Short Interest Over TimeCNBX Days to Cover Over TimeCNBX Percentage of Float Shorted Over Time CNBX Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 2/28/20253,800 shares $28.88 +3,700.0%N/A0 $0.01 2/15/2025100 shares $1.00 -99.9%N/A0 $0.01 1/31/202589,100 shares $953.37 No ChangeN/A0.4 $0.01 12/15/202419,100 shares $171.90 -87.6%N/A0.1 $0.01 11/30/2024154,200 shares $1,156.50 -19.0%N/A4.4 $0.01 11/15/2024190,400 shares $1,542.24 +2,438.7%N/A0.8 $0.01 10/31/20247,500 shares $59.25 -11.8%N/A0 $0.01 10/15/20248,500 shares $79.90 No ChangeN/A0 $0.01 9/30/20248,500 shares $59.50 No ChangeN/A0.1 $0.01 7/31/2024100 shares $0.67 -50.0%N/A0 $0.01 Get the Latest News and Ratings for CNBX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for CNBX Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 7/15/2024200 shares $1.28 -83.3%N/A0 $0.01 6/30/20241,200 shares $6.84 -70.7%N/A0 $0.01 6/15/20244,100 shares $38.54 -72.9%N/A0 $0.01 5/31/202415,100 shares $135.90 No ChangeN/A0 $0.01 4/30/20242,200 shares $32.56 No ChangeN/A0 $0.01 3/31/2024300 shares $4.77 +200.0%N/A0 $0.02 3/15/2024100 shares $1.60 No ChangeN/A0 $0.02 2/15/20241,500 shares $18.75 -92.5%N/A0 $0.01 1/15/202423,000 shares $370.30 +11,400.0%N/A0 $0.02 12/31/2023200 shares $2.84 No ChangeN/A0 $0.01 11/15/202330,100 shares $376.25 +9,933.3%N/A0.1 $0.01 10/31/2023300 shares $5.10 No ChangeN/A0 $0.02 9/30/202335,000 shares $612.50 No ChangeN/A0 $0.02 8/31/2023100 shares $1.69 -99.2%N/A0 $0.02 8/15/202312,100 shares $177.87 +105.1%N/A0 $0.01 7/31/20235,900 shares $91.45 -83.8%N/A0 $0.02 7/15/202336,400 shares $436.80 No ChangeN/A0.1 $0.01 6/15/20239,200 shares $180.32 -39.1%N/A0 $0.02 5/31/202315,100 shares $312.57 +3,675.0%N/A0 $0.02 5/15/2023400 shares $5.84 No ChangeN/A0 $0.01 3/31/20231,200 shares $44.40 -86.2%N/A0 $0.04 3/15/20238,700 shares $717.75 +1,350.0%N/A0 $0.08 2/28/2023600 shares $58.50 No ChangeN/A0 $0.10 1/31/2023300 shares $81.00 +200.0%N/A0 $0.27 1/15/2023100 shares $95.00 No ChangeN/A0 $0.95 12/15/2022100 shares $400.00 -80.0%N/A0.2 $4.00 11/30/2022500 shares $1,980.00 +66.7%N/A1 $3.96 11/15/2022300 shares $1,110.00 +200.0%N/A0.3 $3.70 10/31/2022100 shares $382.50 No ChangeN/A0.2 $3.83 8/15/2022600 shares $2,400.00 No ChangeN/A0.7 $4.00New “Trump” currency proposed in DC (Ad)According to one of the most connected men in Washington… A surprising new bill was just introduced in Washington. Its purpose: to put Donald Trump’s face on the $100 note. All to celebrate a new “golden age” for America. When you see what could happen – I think you’ll be excited. 6/30/2022100 shares $354.00 No ChangeN/A0.2 $3.54 6/15/2022100 shares $390.00 No ChangeN/A0.1 $3.90 4/30/20229,700 shares $758.54 -72.8%N/A0.1 $0.08 4/15/202235,600 shares $3,011.76 -59.7%N/A0.2 $0.08 3/31/202288,300 shares $7,752.74 +4,805.6%N/A0.3 $0.09 3/15/20221,800 shares $119.16 -83.8%N/A0 $0.07 2/28/202211,100 shares $888.00 No ChangeN/A0.1 $0.08 12/31/202170,900 shares $5,565.65 No ChangeN/A0.1 $0.08 11/30/20215,800 shares $768.50 +34.9%N/A0 $0.13 11/15/20214,300 shares $580.50 -18.9%N/A0 $0.14 10/29/20215,300 shares $795.00 +657.1%N/A0 $0.15 10/15/2021700 shares $97.86 -88.9%N/A0 $0.14 9/30/20216,300 shares $975.24 +14.6%N/A0 $0.15 9/15/20215,500 shares $869.00 -28.6%N/A0 $0.16 8/31/20217,700 shares $1,309.00 +250.0%N/A0 $0.17 8/13/20212,200 shares $378.18 -97.4%N/A0 $0.17 7/30/202184,200 shares $14,128.76 +306.8%N/A0.4 $0.17 7/15/202120,700 shares $3,726.00 -50.1%N/A0.1 $0.18 6/30/202141,500 shares $7,739.75 -85.5%N/A0.2 $0.19 6/15/2021286,300 shares $54,397.00 +24.2%N/A0.7 $0.19 5/28/2021230,600 shares $44,782.52 +8.6%N/A1 $0.19 5/14/2021212,300 shares $40,761.60 -49.4%N/A0.6 $0.19 4/30/2021419,400 shares $78,637.50 +82.2%N/A0.6 $0.19 4/15/2021230,200 shares $51,564.80 -83.7%N/A0.3 $0.22 3/31/20211,407,900 shares $341,415.75 +94.4%N/A3.1 $0.24 3/15/2021724,200 shares $287,507.40 +7.8%N/A1.3 $0.40 2/26/2021672,100 shares $322,608.00 +2.9%N/A0.7 $0.48 2/12/2021653,000 shares $336,295.00 -0.2%N/A0.4 $0.52 1/29/2021654,300 shares $189,354.42 +2.2%N/A1.2 $0.29 1/15/2021526,200 shares $125,235.60 -11.3%N/A1.1 $0.24 12/31/2020585,000 shares $128,700.00 +11.2%N/A1.9 $0.22 12/15/2020526,200 shares $141,916.14 -11.3%N/A1.1 $0.27 11/30/2020593,200 shares $172,028.00 +0.4%N/A0.5 $0.29 11/15/2020591,100 shares $112,309.00 +0.8%N/A3.6 $0.19 10/30/2020586,600 shares $105,588.00 +0.0%N/A2.6 $0.18 10/15/2020586,400 shares $96,756.00 -0.9%N/A5.5 $0.17 9/30/2020591,800 shares $97,647.00 -4.2%N/A9.4 $0.17 9/15/2020617,600 shares $110,673.92 +4.9%N/A3.7 $0.18 8/31/2020588,600 shares $112,422.60 +0.4%N/A4 $0.19 8/14/2020586,400 shares $113,761.60 No ChangeN/A4.2 $0.19 7/31/2020586,400 shares $117,338.64 No ChangeN/A3.1 $0.20 7/15/2020586,400 shares $124,610.00 0.0%N/A3.8 $0.21 6/30/2020586,500 shares $139,117.80 -0.9%N/A2.4 $0.24 6/15/2020591,700 shares $162,244.14 -0.3%N/A1.4 $0.27 5/29/2020593,200 shares $161,647.00 -0.6%N/A1.6 $0.27 5/15/2020596,900 shares $131,198.62 +0.3%N/A2.4 $0.22 4/30/2020595,300 shares $129,477.75 -2.3%N/A0.9 $0.22 CNBX Short Interest - Frequently Asked Questions What is CNBX Pharmaceuticals' current short interest? Short interest is the volume of CNBX Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of February 28th, traders have sold 3,800 shares of CNBX short. Learn More on CNBX Pharmaceuticals' current short interest. Is CNBX Pharmaceuticals' short interest increasing or decreasing? CNBX Pharmaceuticals saw a increase in short interest in February. As of February 28th, there was short interest totaling 3,800 shares, an increase of 3,700.0% from the previous total of 100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does CNBX Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the industry of "cannabis" compare to CNBX Pharmaceuticals: Innovative Industrial Properties, Inc. (5.63%), GrowGeneration Corp. (6.96%), Grow Capital, Inc. (0.00%), Trees Co. (0.00%), Net Savings Link, Inc. (0.01%), 22nd Century Group, Inc. (0.93%), Pervasip Corp. (0.00%), and Mentor Capital, Inc. (0.01%). Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($23.74 billion), iShares 20+ Year Treasury Bond ETF ($10.75 billion), Strategy Incorporated ($6.56 billion), Apollo Global Management, Inc. ($5.40 billion), Charter Communications, Inc. ($4.57 billion), AppLovin Co. ($4.45 billion), Capital One Financial Co. ($4.33 billion), Super Micro Computer, Inc. ($4.23 billion), Schlumberger Limited ($3.22 billion), and Royal Caribbean Cruises Ltd. ($3.06 billion). View all of the most shorted stocks. What does it mean to sell short CNBX Pharmaceuticals stock? Short selling CNBX is an investing strategy that aims to generate trading profit from CNBX Pharmaceuticals as its price is falling. CNBX shares are trading up $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against CNBX Pharmaceuticals? A short squeeze for CNBX Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CNBX, which in turn drives the price of the stock up even further. How often is CNBX Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CNBX, twice per month. The most recent reporting period available is February, 28 2025. More Short Interest Resources from MarketBeat Related Companies AmeriCann Short Interest Cannabis Sativa Short Interest GB Sciences Short Interest Medical Marijuana Short Interest Ultrack Systems Short Interest WEED Short Interest Zoned Properties Short Interest Innovative Industrial Properties Short Interest GrowGeneration Short Interest Grow Capital Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:CNBX) was last updated on 4/25/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored"I'm risking my reputation on this"I've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CNBX Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CNBX Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.